Top 10 Companies in Point of Care Diagnostics Market

With the growing need for early disease diagnosis and improved patient outcomes, in-vitro diagnostics is shifting from centralized laboratories to decentralized point-of-care (POC) testing. POC testing is gaining traction as it enables rapid detection of analytes near to the patient, which facilitates quick medical decisions and better disease diagnosis, monitoring, and management.

The global point of care diagnostics/testing market is expected to reach $30.9 billion by 2024 from $19.5 billion in 2018, growing at a CAGR of 8.0% during the forecast period (2018 to 2024).

Here are the Top 10 Companies in Point of Care Diagnostics/Testing :

Abbott Laboratories

abbottIncorporated in 1900 and headquartered at Chicago, Illinois, the U.S., Abbott Laboratories is engaged in the discovery, development, manufacture, and sale of wide range of health care products. Abbott Laboratories has four reportable segments: Established pharmaceutical products, diagnostic products, nutritional products, and cardiovascular and neuromodulation products. The company offers point of care and rapid diagnostic products under Diagnostic products business segment. The company acquired Alere Inc. in October 2017.

This acquisition strengthened its portfolio of point of care diagnostics. The company has strong presence in North America, Europe, Asia-Pacific, and rest of the world. Abbott Laboratories Argentina, S.A., Abbott B.V., and Abbott Manufacturing Singapore Private Ltd are some of the major subsidiaries of the company.

AccuBioTech Co., Ltd.

Established in 1999 and headquartered at Beijing, China; AccuBioTech Co., Ltd. is a leading manufacturer and supplier of in vitro diagnostic tests and laboratory equipment. The company has extensive product portfolio which includes pregnancy test, infectious disease test, sexually transmitted disease test, fecal occult blood test, tumor markers, cardiac tests, drug of abuse test, urine reagent strip, alcohol tests, blood glucose test, urine reagent test reader, Elisa reader, Elisa washer, and biochemistry analyzer. The company provides its products to hospitals, clinical labs, physicians‟ offices, home care, and law enforcement offices in 50 countries around the globe.

The company has an established quality management system for medical devices according to the requirement specified in EN 13485:2012. The company has a headcount of around 100 employees and has a strong geographic presence across North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Becton Dickinson and Company

Becton, Dickinson and Company (U.S.)Founded in 1897 and headquartered at New Jersey, the U.S.; Becton Dickinson and Company is engaged in medical technology for improving medical discovery, diagnostics, and delivery of care. The company operates in three business segments namely, BD Medical, BD Life Sciences, and BD Interventional. The company provides solutions that facilitate medical research and genomics, enhance diagnosis of infectious diseases, improve medication management, promote infection prevention, equip surgical and interventional procedures, and support the management of diabetes leading to patient and healthcare worker safety. The company provides life sciences and analytical instruments under BD life sciences business segment through its subsidiary PharMingen.

With its subsidiaries and strong network of distributors, the company has its presence in more than 50 countries across North America, Europe, Asia-Pacific, Latin America and Middle East & Africa. The company has subsidiaries such as Becton Dickinson A.G., Becton Dickinson and Company India Pvt Ltd., Becton Dickinson and Company Canada Inc., PharMingen, and more.

Chembio Diagnostic Systems, Inc.

Founded in 1985 and headquartered in New York, the U.S.; Chembio Diagnostic Systems, Inc. manufactures, develops, and licenses rapid point of care diagnostics tests that detects infectious diseases. The company offers human and veterinary diagnostics tests. The company mainly provides rapid tests for the detection of HIV 1/2 antibodies, and a multiplex rapid test for the detection of HIV and syphilis antibodies. The company recently developed latest generation HIV 1/2 rapid antibody detection test based on Dual Path Platform (DPP) POCT technology, and this POCT platform does not require in-licensing. The DPP HIV 1/2 Assay detects antibodies to HIV 1 & 2 in oral fluid samples as well as in all blood matrices.

The company has a strong geographic presence in North America, Europe, Asia, South America, and Africa.

Danaher Corporation

Founded in 1969 and headquartered at Washington, the U.S.; Danaher Corporation designs, manufactures and markets professional, medical, industrial and commercial products and services. The company operates through four business segments namely, Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.

The diagnostics segment offers analytical instruments, reagents, consumables, software and services mainly used by hospitals, physicians‟ offices, reference laboratories and other critical care settings used to diagnose disease and make treatment decisions. Danaher established the diagnostics business in 2004 through the acquisition of Radiometer and expanded the business through numerous subsequent acquisitions, including the acquisitions of Vision Systems in 2006, Genetix in 2009, Beckman Coulter in 2011, Iris International and Aperio Technologies in 2012, HemoCue in 2013, Devicor Medical Products in 2014, the clinical microbiology business of Siemens Healthcare Diagnostics in 2015 and Cepheid in 2016. The diagnostics business consists of the clinical laboratory (or clinical lab), molecular, critical care and anatomical pathology diagnostics businesses.

The company has a strong geographic presence across North America, Europe, Asia-Australia, Latin America, and Middle East & Africa.

A report into the projected growth of the current Point Of Care Diagnostics Market by Meticulous Research® has produced some incredible forecasts for the industry. By 2024, it’s expected to have grown at a CAGR of 8%, reaching over $ 30 billion.

EKF Diagnostics Holdings plc

Founded in 1990 and headquartered in Cardiff, the U.K.; EKF Diagnostics Holdings plc manufactures, designs, develops and sells diagnostic instruments, and reagents all across the globe. The company‟s POC tests are easy to use, reliable and provide accuracy for the professionals working in diabetes, blood banking and sports medicine fields. The point of care tests comprises of hemoglobin analyzers, diabetes care, maternal & women‟s health, and sports performance. The company sells its products directly to GPs, sports and diabetes clinics, blood banks, hospitals, laboratories, and government agencies, as well as through a network of distributors.

The company has a strong geographic presence across Americas, Europe & Middle East & Africa, Asia, and Rest of World.

WerfenLife, S.A.

Founded in 1966 and headquartered in Barcelona, Spain; WerfenLife, S.A., is a privately held corporation that operates through its subsidiaries which develop, manufactures, and distributes in vitro diagnostics solutions to enhance patient care. The Werfen comprise of 30 affiliates, distributors, and companies including (Hemostasis, Acute Care Diagnostics), Inova Diagnostics (Autoimmunity) and Biokit (OEM, infectious disease serology). The company‟s portfolio comprises of healthcare instruments, software, reagents, and services. It offers hemostasis, critical care, autoimmunity, serology, and clinical chemistry diagnostics, as well as clinical software products.

Instrumentation Laboratory, a Werfen company is a worldwide developer, manufacturer and distributor of instruments, related reagents and data management solutions, for use primarily in hospitals, at the point of care and in the laboratory. The Instrumentation Laboratory solutions include Hemostasis and Acute Care Diagnostic products and services. The manufacturing facilities of the company are present in the U.S., Spain, and Italy. The company has a strong geographic presence across North America, Europe, Asia-pacific, Latin America, and Middle East & Africa.

Johnson and Johnson Service, Inc.

johnson and johnsonIncorporated in 1887 and headquartered at New Jersey, the U.S.; Johnson and Johnson Service, Inc. is engaged in research and development, manufacture, and sales of wide range of products in healthcare field. The company operates through three business segments- Consumer, Pharmaceuticals, and Medical Devices segment comprises of a broad range of products used in the orthopedic, surgery, cardiovascular, diabetes care and eye health fields. The company provides point of care diagnostic products through LifeScan. LifeScan offers blood glucose monitoring products such as personal blood glucose meters, testing strips, lancets, point-of-care testing devices and integrated digital solutions under the OneTouch brand. However, recently, in October 2018, J&J completed the sale of its subsidiary LifeScan to private investment firm Platinum Equity for a total consideration of around $2.1bn.

The Company has a strong geographic presence across the U.S., Europe, Asia-Pacific, Western Hemisphere, and Africa.

Nova Biomedical

Incorporated in 1976 and headquartered in Waltham, U.S.; Nova Biomedical develops, manufactures, and sells advanced technology blood testing analysers and diagnostics products to healthcare companies. The company has a broad range of portfolio including hospital blood gas and critical care analysers, chemistry and cell analysers for biotechnology, self-testing diabetes monitoring systems, hospital point-of-care connectivity meters and strips, veterinary blood gas and critical care analysers, veterinary point-of-care analysers, veterinary analysers, and lactate measuring systems for athletes.

The company also provides hospital glucose monitoring systems, hospital glucose/ketone monitoring systems, point-of-care whole blood creatinine and eGFR testing products, electrolyte/chemistry analysers, prime electrolyte analysers, blood lactate meters for sports training and conditioning, muscle performance indicators, and blood beta hydroxybutyrate meters. Further, the company provides contract manufacturing services. It markets and sells its products through distributors in North America, Europe, Russia, Eastern Europe, the Middle East, Africa, Asia, the Pacific Islands, Latin America, the Indian Subcontinent, and internationally.

F. Hoffmann-La Roche Ltd.

Founded in 1896 and headquartered at Basel, Switzerland; F. Hoffmann-La Roche Ltd. operates through two divisions namely, pharmaceuticals and diagnostics which are focused on advancing science to improve people‟s lives. Pharmaceutical division is comprised of two business segments namely, Roche Pharmaceuticals and Chugai whereas Diagnostic division consists of four business areas namely, Centralised and Point of Care Solutions, Diabetes Care, Molecular Diagnostics, and Tissue Diagnostics. These business areas focus on health care applications targeting physicians, hospitals and clinics, and consumers.

Roche Diagnostics Corporation a subsidiary of F. Hoffmann-La Roche Ltd., manufactures tools that help healthcare providers in the prevention, diagnosis, and management of various diseases. Roche Diagnostics Corporation was formerly known as Boehringer Mannheim Corporation and changed its name to Roche Diagnostics Corporation in December 1998. The company offers assays, reagents, instruments, systems, laboratory systems and automation products, QC, calibration products, and biosensors. It also provides point of care testing products for blood glucose, anticoagulation management, blood gas and electrolyte, cholesterol, urinalysis, infectious diseases, and molecular products including systems, donor screening products, and automation products.

With its subsidiaries and strong network of distribution, the company has its presence in North America, Europe, Asia-Pacific, and Latin America & Middle East Africa.

Popular Mentions: Sekisui Chemical Co. Ltd., Quidel Corporation, Siemens Healthcare GmbH/Siemens Healthineers, and Trinity Biotech

Authoritative Research on the Point Of Care Diagnostics Market – Global Opportunity Analysis and Industry Forecast (2018-2024)

Need more information? Meticulous Research®’s new report covers each of these companies in much more detail, providing analysis on the following:

  • Recent financial performance
  • Key products
  • Significant company strategies
  • Partnerships and acquisitions

The Comprehensive report provides global market size estimates, market share analysis, revenue numbers, and coverage of key issues and trends.

Please download report pages and learn more:

Leave a Reply

Your email address will not be published. Required fields are marked *